Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen injection for postoperative moderate-to-severe pain
CTR20150624Phase 3Active
- Sponsor
- Tianjin Hankang Pharmaceutical Biotechnology
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibuprofen in postoperative pain, sponsored by Tianjin Hankang Pharmaceutical Biotechnology. Started Dec 2016; status: active.
02
Drugs
ibuprofen
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20150624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150624.